The prime minister set out his "plan for change" in a major speech which covered priorities including the economy
The article from BBC News discusses the ongoing debate over the use of puberty blockers for transgender youth in the UK. It highlights the recent decision by NHS England to restrict the use of these drugs to clinical research trials only, following a review that raised concerns about the lack of long-term data on their effects. Puberty blockers, which pause the physical changes of puberty, have been a point of contention, with advocates arguing they provide crucial time for young people to explore their gender identity without the pressure of unwanted physical changes. Critics, however, express worries about potential irreversible effects on bone density, brain development, and fertility. The article also touches on the emotional and psychological impact on transgender youth and their families, with some feeling that the decision limits their options for care. Furthermore, it mentions the broader political and cultural debate surrounding transgender healthcare, with different countries adopting varied approaches to the treatment of gender dysphoria in minors.
